Blood Test Based (Blood Analyses) Equipment
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
AlphaLiquid® Screening is a blood-based test for early detection of multiple cancers. With 10mL of blood, the test analyzes genetic and epigenetic features in cfDNA to screen for signals of cancer as well as predict the tissue of origin. ...
-
Manufactured by GENFITbased in FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of ...
-
Manufactured by OncoDiagbased in FRANCE
An accurate blood-based test for the screening of colorectal cancer ...
-
Manufactured by Amadixbased in SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal Cancer (CRC) ...
-
Manufactured by Endodiagbased in FRANCE
EndoDTectis a blood test based on the analysis of a combination of biomarkers. Changes in their expression levels indicate if a subject has endometriosis or not. Combining high sensitivity and specificity, EndoDTect has the potential to dramatically reduce diagnosis delays. Endodiag is currently conducting validation studies to ...
-
Manufactured by nVectorbased in USA
Blood-based test for neuronal injury / TBI / concussion using a panel of different proteins. A blood-based assay for early detection of neurologic disorders is an exciting and new advancement made available to primary care physicians. This test would be useful for rapid neurology referrals for ...
-
Manufactured by Epigenomics AGbased in GERMANY
as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells. Epi proColon® is the first and only FDA-approved blood-based test for the detection of colorectal cancer. The ...
-
Manufactured by OraSure Technologiesbased in USA
Q.E.D.® Saliva Alcohol Test is a CLIA-waived and DOT-approved, on-site, rapid, low-cost alternative to breath or blood testing. Q.E.D.® is easy to administer and provides quantitative results comparable to a blood test. Q.E.D.® is ideal for use in workplace, criminal justice, drug and alcohol ...
-
Manufactured by Provista Diagnosticsbased in USA
A simple blood test to detect breast cancer with high accuracy in women with abnormal imaging findings. Coming in 2023 the only blood test to rule out breast cancer with >98% accuracy in women with suspicious imaging findings, irrespective of breast ...
-
Manufactured by Provista Diagnosticsbased in USA
Limitations of Current Cancer Screening: Screening tests for cancers in general, and breast, colon, and lung cancers specifically, have well known constraints and compliance shortcomings. Either the procedures are too invasive or they lack accuracy or the most effective diagnostics remain too expensive for widespread adoption for all ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you